Table 5.
CHEERS quality rating
| CHEERS item | [29] | [28] | [20] | [25] | [32] | [33] | [26] | [30] | [34] | [21] | [31] | [27] | [24] | [22] | [35] | [23] | [36] | [19] | Mean |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Titlea | 1 | 1 | N/A | 1 | N/A | N/A | 1 | 1 | N/A | N/A | 1 | 1 | N/A | 1 | 1 | N/A | N/A | 1 | 100% |
| 2 Abstract | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 | 97% |
| 3 Background | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 100% |
| 4 Population | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 100% |
| 5 Setting | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 100% |
| 6 Perspective | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.5 | 1 | 0 | 1 | 1 | 92% |
| 7 Comparators | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | N/A | 1 | 1 | 1 | 1 | N/A | 1 | 1 | 1 | 100% |
| 8 Time horizon | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | N/A | 1 | 1 | 1 | 94% |
| 9 Discount rate | 1 | 0 | 0 | 0 | N/A | N/A | 0 | 0 | N/A | N/A | 0 | 0 | 0 | 0 | N/A | 0 | N/A | 0 | 8% |
| 10 Choice of health outcomes | N/A | 1 | 0.5 | N/A | 1 | 1 | N/A | 1 | 1 | N/A | 1 | N/A | N/A | 1 | N/A | 1 | 1 | 1 | 95% |
| 11 Effectiveness | N/A | 1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 100% |
| 12 Measurement /valuation | 1 | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1 | N/A | 1 | 1 | N/A | N/A | N/A | N/A | 80% |
| 13 Resources & costs | 1 | 1 | 1 | 1 | N/A | 1 | 1 | 1 | N/A | N/A | 1 | 1 | N/A | 1 | N/A | 0 | N/A | 1 | 92% |
| 14 Currency/ price conversion | 1 | 1 | 1 | 1 | N/A | N/A | 1 | 0.5 | 0 | N/A | 0 | 1 | 1 | 0.5 | N/A | 1 | N/A | 0.5 | 73% |
| 15 Model choice | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0.5 | 1 | 1 | 1 | N/A | 0 | 1 | 1 | 79% |
| 16 Assumptions | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | N/A | 0 | 1 | 1 | 59% |
| 17 Analysis | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 89% |
| 18 Parameters | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0.5 | 1 | 1 | 92% |
| 19 Incremental costs/outcomes | N/A | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | N/A | 1 | 1 | 1 | 88% |
| 20 Uncertainty | 0 | 1 | N/A | N/A | N/A | N/A | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | 1 | 40% |
| 21 Heterogeneity | 1 | 1 | N/A | 1 | N/A | N/A | N/A | 1 | N/A | N/A | N/A | N/A | N/A | 1 | N/A | N/A | 1 | 1 | 100% |
| 22 Discussion | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 | 1 | 1 | 0.5 | 94% |
| 23 Funding | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 83% |
| 24 Conflicts | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 83% |
| Mean score | 90% | 88% | 76% | 90% | 100% | 100% | 75% | 88% | 76% | 93% | 79% | 95% | 81% | 91% | 100% | 65% | 100% | 82% | 87% |
aStudies with N/A for "Title" were not focused on economic evaluation, but included costing; 0.5 indicates partial fulfillment of the criteria